Lv1
14 积分 2025-11-19 加入
Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review
1天前
待确认
CD19 CAR T-cell therapy for connective tissue disease-associated pulmonary arterial hypertension
2天前
求助中
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
8天前
已完结
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma
22天前
已完结
Linperlisib Plus Chidamide in Relapsed or Refractory Cutaneous T-Cell Lymphoma
26天前
已完结
Incidence of enteropathy - associated T-cell lymphoma: A nation-wide study of a population-based registry in The Netherlands
26天前
已完结
Autologous CD19/BCMA CAR-T cell therapy for myasthenia gravis: Advancing care for those with severe disease
1个月前
已完结
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy
1个月前
已完结
Irreversible parkinsonism after idecabtagene vicleucel: long-term outcome of a rare BCMA CAR T-cell neurotoxicity
1个月前
已完结
Multiple Myeloma and Mimicry: Gastrointestinal Tract Histologic Findings in Patients Following Chimeric Antigen Receptor T-cell Therapy and Anti-CD38 Monoclonal Antibodiesx
1个月前
已关闭
皖公网安备34019202002308
